Founded in 2008, IM Cannabis Corp. is a medical cannabis producer and supplier operating primarily in Israel and Germany. The company engages in cultivation, breeding, and processing of cannabis plants to manufacture finished medical products for patient consumption. Its product portfolio includes dried cannabis flowers and cannabis extracts distributed under multiple brands including IMC, BLKMT, WAGNERS, and LOT420.
The company's primary revenue stream derives from the sale of medical cannabis products to licensed dispensaries and medical patients in its operating jurisdictions. IM Cannabis focuses on the medical cannabis segment rather than recreational markets, positioning itself within the regulated pharmaceutical cannabis supply chain.
The company maintains cultivation and processing facilities in both Israel and Germany, with headquarters in Tel Aviv. Specific information regarding employee count and precise revenue figures is not disclosed in available data, though the company's micro-cap valuation indicates a relatively small operational scale within the global cannabis industry. IM Cannabis is incorporated in British Columbia, Canada, and maintains listings on Nasdaq.
No 10-K filings found.